SEARCH

SEARCH BY CITATION

References

  • 1
    Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 6066.
  • 2
    Salmi M, Jalkanen S. VAP-1: an adhesin and an enzyme. Trends Immunol 2001; 22: 211216.
  • 3
    Smith DJ, Salmi M, Bono P, Hellman J, Leu T, Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J Exp Med 1998; 188: 1727.
  • 4
    Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005; 5: 760771.
  • 5
    Salmi M, Yegutkin GG, Lehvonen R, Koskinen K, Salminen T, Jalkanen S. A cell surface amine oxidase directly controls lymphocyte migration. Immunity 2001; 14: 265276.
  • 6
    Hernandez M, Sole M, Boada M, Unzeta M. Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells. Biochim Biophys Acta 2006; 1763: 164173.
  • 7
    Zorzano A, Abella A, Marti L, Carpene C, Palacin M, Testar X. Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells. Biochim Biophys Acta 2003; 1647: 39.
  • 8
    Bonder CS, Norman MU, Swain MG, Zbytnuik LD, Yamanouchi J, Santamaria P, et al. Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1. Immunity 2005; 23: 153163.
  • 9
    Kurkijarvi R, Adams DH, Leino R, Mottonen T, Jalkanen S, Salmi M. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J Immunol 1998; 161: 15491557.
  • 10
    Kurkijarvi R, Yegutkin GG, Gunson BK, Jalkanen S, Salmi M, Adams DH. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease. Gastroenterology 2000; 119: 10961103.
  • 11
    Lalor PF, Edwards S, McNab G, Salmi M, Jalkanen S, Adams DH. Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells. J Immunol 2002; 169: 983992.
  • 12
    Yu PH, Davis BA, Boulton AA, Zuo DM. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. J Neural Transm Suppl 1994; 41: 397406.
  • 13
    Salmi M, Hellman J, Jalkanen S. The role of two distinct endothelial molecules, vascular adhesion protein-1 and peripheral lymph node addressin, in the binding of lymphocyte subsets to human lymph nodes. J Immunol 1998; 160: 56295636.
  • 14
    Yu PH, Wright S, Fan EH, Lun ZR, Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 2003; 1647: 193199.
  • 15
    Merinen M, Irjala H, Salmi M, Jaakkola I, Hanninen A, Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 2005; 166: 793800.
  • 16
    Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 27452756.
  • 17
    Salmi M, Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science 1992; 257: 14071409.
  • 18
    Ahmed-Choudhury J, Russell CL, Randhawa S, Young LS, Adams DH, Afford SC, et al. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Mol Biol Cell 2003; 14: 13341345.
  • 19
    Curbishley SM, Eksteen B, Gladue RP, Lalor P, Adams DH. CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am J Pathol 2005; 167: 887899.
  • 20
    Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 2005; 68: 2636.
  • 21
    Enrique-Tarancon G, Castan I, Morin N, Marti L, Abella A, Camps M, et al. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor- substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells. Biochem J 2000; 350: 171180.
  • 22
    Fantus IG, Kadota S, Deragon G, Foster B, Posner BI. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 1989; 28: 88648871.
  • 23
    May MJ, Wheeler-Jones CP, Pearson JD. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells. Br J Pharmacol 1996; 118: 17611771.
  • 24
    McNab G, Reeves JL, Salmi M, Hubscher S, Jalkanen S, Adams DH. Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium. Gastroenterology 1996; 110: 522528.
  • 25
    Edwards S, Lalor PF, Nash GB, Rainger GE, Adams DH. Lymphocyte traffic through sinusoidal endothelial cells is regulated by hepatocytes. HEPATOLOGY 2005; 41: 451459.
  • 26
    Martelius T, Salaspuro V, Salmi M, Krogerus L, Hockerstedt K, Jalkanen S, et al. Blockade of vascular adhesion protein-1 inhibits lymphocyte infiltration in rat liver allograft rejection. Am J Pathol 2004; 165: 19932001.
  • 27
    Durieu-Trautmann O, Chaverot N, Cazaubon S, Strosberg AD, Couraud PO. Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem 1994; 269: 1253612540.
  • 28
    Salmi M, Jalkanen S. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells—implications for lymphocyte-endothelial cell adhesion models. Eur J Immunol 1995; 25: 28032812.
  • 29
    Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, et al. Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 2004; 279: 16151620.
  • 30
    Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy—from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 2005; 1754: 253262.
  • 31
    Marti L, Morin N, Enrique-Tarancon G, Prevot D, Lafontan M, Testar X, et al. Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide. J Pharmacol Exp Ther 1998; 285: 342349.
  • 32
    Chen F, Demers LM, Vallyathan V, Ding M, Lu Y, Castranova V, et al. Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK/ERK kinase 1 in macrophages. J Biol Chem 1999; 274: 2030720312.
  • 33
    O'Sullivan J, Unzeta M, Healy J, O'Sullivan MI, Davey G, Tipton KF. Semicarbazide-sensitive amine oxidases: enzymes with quite a lot to do. Neurotoxicology 2004; 25: 303315.
  • 34
    Rodriguez C, Raposo B, Martinez-Gonzalez J, Casani L, Badimon L. Low density lipoproteins downregulate lysyl oxidase in vascular endothelial cells and the arterial wall. Arterioscler Thromb Vasc Biol 2002; 22: 14091414.
  • 35
    Levene CI, Heale G, Robins SP. Collagen cross-link synthesis in cultured vascular endothelium. Br J Exp Pathol 1989; 70: 621626.
  • 36
    Johnston B, Kanwar S, Kubes P. Hydrogen peroxide induces leukocyte rolling: modulation by endogenous antioxidant mechanisms including NO. Am J Physiol 1999; 271: H614H621.
  • 37
    Okayama N, Ichikawa H, Coe L, Itoh M, Alexander JS. Exogenous NO enhances hydrogen peroxide-mediated neutrophil adherence to cultured endothelial cells. Am J Physiol 1998; 274: L820L826.
  • 38
    True AL, Rahman A, Malik AB. Activation of NF-kappaB induced by H(2)O(2) and TNF-alpha and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 2000; 279: L302L311.
  • 39
    Tohka S, Laukkanen M, Jalkanen S, Salmi M. Vascular adhesion protein 1 (VAP-1) functions as a molecular brake during granulocyte rolling and mediates recruitment in vivo. FASEB J 2001; 15: 373382.
  • 40
    O'Sullivan J, O'Sullivan M, Tipton KF, Unzeta M, Del Mar HM, Davey GP. The inhibition of semicarbazide-sensitive amine oxidase by aminohexoses. Biochim Biophys Acta 2003; 1647: 367371.